We are live on ! Find out more
ANRO icon

Alto Neuroscience
ANRO

77 hedge funds and large institutions have $95.3M invested in Alto Neuroscience in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 31 increasing their positions, 10 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

210% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 10

3% more funds holding

Funds holding: 75 → 77 (+2)

9% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 22

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1.55% less ownership

Funds ownership: 85.09% → 83.54% (-1.5%)

48% less call options, than puts

Call options by funds: $136K | Put options by funds: $260K

64% less capital invested

Capital invested by funds: $265M → $95.3M (-$170M)

Holders
77
Holders Change
+2
Holders Change %
+2.67%
% of All Funds
1.01%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
31
Reduced
10
Closed
22
Calls
$136K
Puts
$260K
Net Calls
-$124K
Net Calls Change
-$3.54M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$6.09M
2
Marshall Wace
Marshall Wace
United Kingdom
+$5.23M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.46M
4
AC
Armistice Capital
New York
+$4.06M
5
WP
Woodline Partners
California
+$3.1M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$23.7M
2
ECM
ExodusPoint Capital Management
New York
-$13.3M
3
Jennison Associates
Jennison Associates
New York
-$9.52M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.85M
5
PFMOSF
Philadelphia Financial Management of San Francisco
California
-$5.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$655K -$201K -32,137 -17%
N
27
Nuveen
North Carolina
$592K -$383K -61,310 -30%
Stifel Financial
28
Stifel Financial
Missouri
$544K +$803K +128,700 New
Goldman Sachs
29
Goldman Sachs
New York
$471K +$410K +65,740 +144%
TD Asset Management
30
TD Asset Management
Ontario, Canada
$469K +$211K +33,800 +44%
BFM
31
Boothbay Fund Management
New York
$436K +$643K +103,100 New
LNWWM
32
Laird Norton Wetherby Wealth Management
California
$356K – – –
Wellington Management Group
33
Wellington Management Group
Massachusetts
$326K +$103K +16,510 +27%
IC
34
IEQ Capital
California
$276K – – –
Manulife (Manufacturers Life Insurance)
35
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$264K -$21.3K -3,414 -5%
Allianz Asset Management
36
Allianz Asset Management
Germany
$263K +$157K +25,200 +68%
Bank of America
37
Bank of America
North Carolina
$239K +$137K +22,007 +64%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$221K +$42.5K +6,812 +15%
LP
39
LMR Partners
United Kingdom
$219K +$323K +51,700 New
GCM
40
Graham Capital Management
Connecticut
$204K +$301K +48,229 New
BNP Paribas Financial Markets
41
BNP Paribas Financial Markets
France
$180K +$238K +38,205 +885%
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$173K +$255K +40,926 New
Barclays
43
Barclays
United Kingdom
$168K +$63.7K +10,208 +34%
CC
44
Corton Capital
Ontario, Canada
$142K +$209K +33,553 New
Two Sigma Investments
45
Two Sigma Investments
New York
$130K +$111K +17,760 +137%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$108K +$31.3K +5,008 +24%
Brown Advisory
47
Brown Advisory
Maryland
$106K +$156K +25,000 New
UOTTAIMCU
48
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$93.8K – – –
Ameriprise
49
Ameriprise
Minnesota
$93.1K +$8.48K +1,359 +7%
BCM
50
Bowie Capital Management
Texas
$82.4K – – –
1
2
3 4

ANRO Hedge Fund Activity: Q4 2024 in Review

77 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Alto Neuroscience (ANRO) for Q4 2024, worth a combined $95.3M — down 64% from $265M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new ANRO positions and 22 closed out — a net gain of 2 holders — while 31 added to existing stakes and 10 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $6.09M. The largest seller was RA Capital Management, exiting entirely with an estimated $23.7M sold.

  • 77 institutional investors held Alto Neuroscience (ANRO) as of Q4 2024, up from 75 in Q3 2024.
  • Funds reported $95.3M of Alto Neuroscience stock for Q4 2024, down 64% quarter-over-quarter.
  • 24 funds opened new Alto Neuroscience positions in Q4 2024 and 22 closed out, a net change of +2 holders.
  • The largest Alto Neuroscience buyer in Q4 2024 was Citadel Advisors, an estimated $6.09M added.
  • The largest Alto Neuroscience seller in Q4 2024 was RA Capital Management, an estimated $23.7M sold.

Based on aggregated 13F filings for Q4 2024.